Access to cath labs impacts long-term mortality in ACS patients


Results of the 2012 Australian and New Zealand SNAPSHOT Acute Coronary Syndrome (ACS) audit have shown that that the availability of a catheterisation laboratory appears to have a significant impact on long-term mortality in ACS patients, which is still substantial.
Definite ACS patients presenting to catheterisation-capable (CC) hospitals were more likely to undergo coronary angiography than those presenting to non-CC hospitals (61.5% v 50.8%; P = 0.0001), receive timely reperfusion (for ST elevation myocardial infarction (STEMI) patients: 45.2% v 19.2%; P < 0.001), and be referred for cardiac rehabilitation (57% v 53%; P = 0.05).

The full article can be found in the Medical Journal of Australia.


Leave a reply

Your email address will not be published. Required fields are marked *


© 2016 Australian Centre for Heart Health | Website designed and managed by Digital Guerilla Web Design Sydney

Log in with your credentials


Forgot your details?